Dental Caries, Cervical Caries
Conditions
Keywords
Silver Diamine Fluoride, SMART Technique, Glass Ionomer Cement, Atraumatic Restorative Treatment, Elderly, Cancer Patients, Cervical Restoration
Brief summary
This study will evaluate the clinical performance of glass ionomer cervical restorations placed using the Silver-Modified Atraumatic Restorative Technique (SMART) compared with conventional restorative treatment in elderly cancer patients with cervical carious lesions. The trial is a 12-month randomized clinical trial with two parallel arms and a 1:1 allocation ratio. SMART arms will receive 38% silver diamine fluoride (SDF) and potassium iodide followed by high-viscosity glass ionomer cement (HVGIC) ), while the conventional arms will receive standard tooth preparation followed by HVGIC without SDF. The primary outcome is retention of the restoration, assessed using USPHS criteria. Secondary outcomes include postoperative hypersensitivity, marginal integrity, recurrent caries, average duration of treatment, anatomic form, color match, surface roughness, marginal discoloration, and patient satisfaction (VAS). Patients will be followed at baseline, 3, 6, 9and 12 months. The study aims to determine whether the minimally invasive SMART approach offers comparable clinical performance to conventional treatment while reducing chair time and discomfort in a medically vulnerable elderly cancer population.
Detailed description
Adult cancer patients (45-55 years) with primary cervical carious lesions will be recruited from the outpatient clinics of the Faculty of Dentistry, Cairo University. Eligible teeth must be vital by pulp sensitivity testing with controlled periodontal conditions; teeth with previous restorations, irreversible pulpitis signs, mobility, resorption, or cuspal loss will be excluded, as will patients with material allergies, fixed orthodontic appliances, pregnancy, or frequent analgesic use that could mask pain. After signing informed consent, participants will be randomized 1:1using a computer-generated sequence (random.org) with allocation concealed via sequentially numbered, opaque, sealed envelopes. The study is Single blinded ( outcome assessors blinded; the treating operator is not blinded). Baseline data collection includes medical/dental history and pre-operative radiographs. Interventions will be applied by a single trained operator following standardized protocols for SDF/GIC placement (SMART arms) or conventional cavity preparation and GIC placement (control arms). Data will be collected on paper/Excel and analyzed using MedCalc software (v22) with Chi-square, Cochran's Q, one-way ANOVA/Tukey post-hoc, and repeated-measures ANOVA/Bonferroni-corrected comparisons, with significance set at p≤0.05 and 80% power. Sample size (29 teeth/group) was calculated using G\*Power based on prior HVGIC retention data. The trial is self-funded, with independent auditing conducted by the co-supervisor.
Interventions
38% Silver Diamine Fluoride applied to the carious lesion using a micro brush for one minute, followed by application of potassium iodide (KI)Applied in the SMART group 1-3 times until the precipitate clears to reduce black staining, prior to restoration. Used in SMART arm only, with no mechanical removal of carious dentin.
PROCEDUREConventional Tooth Preparation
Conventional mechanical excavation of carious dentin using sharp hand instruments and air-turbine handpiece, burs and excavators; selective caries removal , followed by cavity conditioning with 10% polyacrylic acid, rinsing, and drying, prior to restoration. No SDF is applied in this procedure.
High-viscosity glass ionomer restorative cement placed and cured according to tooth location, following either SDF application (SMART arm) or conventional mechanical tooth preparation (control arm).
Sponsors
Cairo University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)
Intervention model description
two parallel arms with 1:1 allocation: SMART arm (SDF+KI followed by HVGIC ) and conventional arm(tooth preparation followed by HVGIC , no SDF).
Eligibility
Sex/Gender
ALL
Age
45 Years to 55 Years
Healthy volunteers
No
Inclusion criteria
* Patient-related criteria: * Adult cancer patients of both genders, aged 45-55 years * Good oral hygiene * Willing to sign the informed consent * Co-operative patients who accept the follow-up period Tooth-related criteria: * Posterior teeth with primary cervical surface caries, ICDAS score: 4-6 * Normal gingival or periodontal conditions. * Teeth vital according to pulp sensitivity tests
Exclusion criteria
* Patient-related criteria: * Allergy to any of the restorative materials * Patients undergoing orthodontic treatment with fixed appliances * Pregnant women * Patients who frequently use analgesics or any drugs that could mask pain Tooth-related criteria: * Teeth with previous restorations * Spontaneous or prolonged pain (more than 15 seconds) after cold test, indicating irreversible pulpitis * Negative sensibility test, periapical radiolucency, or sensitivity to percussion * Mobile teeth indicating periodontal disease or trauma * External or internal resorption * Chipped teeth or cuspal loss
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Retention of Restoration | Baseline, 3 months, 6 months, 9 and 12 months | Evaluation of the presence and integrity of the restoration over the follow-up period, assessed using USPHS criteria (Zhao et al., 2018): Alpha (A) - restoration present; Bravo (B) - partial loss, clinically acceptable; Charlie (C) - clinically unacceptable partial/total loss; Delta (D) - immediate replacement necessary. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Postoperative Hypersensitivity | Baseline, 3 months, 6 months, 9 and 12 months | Assessment of patient-reported sensitivity following restoration placement, evaluated using USPHS criteria (Zhao et al., 2018): Alpha (A) - no hypersensitivity; Bravo (B) - mild or transient hypersensitivity; Charlie (C) - moderate or severe hypersensitivity; |
| Marginal Integrity | Baseline, 3 months, 6 months,9 and 12 months | Description: Evaluation of the continuity and adaptation at the restoration margins, assessed using USPHS criteria (Zhao et al., 2018): Alpha (A) - continuity at the margin; Bravo (B) - slight discontinuity at the margin; Charlie (C) - marginal defects requiring replacement. |
| Recurrent Caries | Baseline, 3 months, 6 months, 9,and 12 months | Detection of caries adjacent to restoration margins, assessed using USPHS criteria (Zhao et al., 2018): Alpha (A) - caries absent; Charlie (C) - caries present. |
| Average Duration of Treatment | perioperatively | Time required to complete the restorative procedure, measured in seconds using a stopwatch (Caro et al., 2012). |
| Anatomic Form | Baseline, 3 months, 6 months, 9 and 12 months | Assessment of whether the restoration correctly mimics the natural contours, height, and functional shape of the original tooth, using USPHS criteria (Zhao et al., 2018): Alpha - restoration continuous with existing anatomic form; Bravo - continuous but not exposing cement or dentin; Charlie - sufficient material lost to expose cement material or dentin. |
| Color Match | Baseline, 3 months, 6 months, 9 and 12 months | Measures how well the shade of the restorative material blends with the neighboring natural tooth structure, using USPHS criteria (Zhao et al., 2018): Alpha - no mismatch; Bravo - mismatch within normal range of color, shade, and translucency; Charlie - mismatch outside normal range. |
| Surface Roughness and Marginal Discoloration | Baseline, 3 months, 6 months, 9 and 12 months | Combined assessment of restoration surface smoothness and marginal staining using USPHS criteria (Zhao et al., 2018): Surface roughness scored Alpha (smooth) to Charlie (rough, cannot be refinished); marginal discoloration scored Alpha (none) to Charlie (discoloration penetrated in pulpal direction). |
| Patient Satisfaction | Immediately after the intervention, and at 3, 6,9, and 12 months | Patient-reported satisfaction with treatment, measured using a Visual Analog Scale (VAS) from 0 (unsatisfied) to 10 (totally satisfied), where the patient marks a vertical line across the scale and the distance in millimeters from the zero end is measured (Golpak, 2020). |
Contacts
CONTACTmarwa ashraf husseiny, Master's candidate
CONTACTRawda Abd ElAziz Hesham Abd ElAziz
Outcome results
None listed